Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus

The histone H3 demethylase Not dead yet-1 (Ndy1/KDM2B) is a physiological inhibitor of senescence. Here, we show that Ndy1 is down-regulated during senescence in mouse embryonic fibroblasts (MEFs) and that it represses the Ink4a/Arf locus. Ndy1 counteracts the senescence-associated down-regulation o...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 106; no. 8; pp. 2641 - 2646
Main Authors Tzatsos, Alexandros, Pfau, Raymond, Kampranis, Sotirios C, Tsichlis, Philip N
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 24.02.2009
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The histone H3 demethylase Not dead yet-1 (Ndy1/KDM2B) is a physiological inhibitor of senescence. Here, we show that Ndy1 is down-regulated during senescence in mouse embryonic fibroblasts (MEFs) and that it represses the Ink4a/Arf locus. Ndy1 counteracts the senescence-associated down-regulation of Ezh2, a component of polycomb-repressive complex (PRC) 2, via a JmjC domain-dependent process leading to the global and Ink4a/Arf locus-specific up-regulation of histone H3K27 trimethylation. The latter promotes the Ink4a/Arf locus-specific binding of Bmi1, a component of PRC1. Ndy1, which interacts with Ezh2, also binds the Ink4a/Arf locus and demethylates the locus-associated histone H3K36me2 and histone H3K4me3. The combination of histone modifications driven by Ndy1 interferes with the binding of RNA Polymerase II, resulting in the transcriptional silencing of the Ink4a/Arf locus and contributing to the Ndy1 immortalization phenotype. Other studies show that, in addition to inhibiting replicative senescence, Ndy1 inhibits Ras oncogene-induced senescence via a similar molecular mechanism.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Communicated by John M. Coffin, Tufts University School of Medicine, Boston, MA, December 23, 2008
1Present address: Massachusetts General Hospital Cancer Center, Simches Research Building, CPZN 4100, 185 Cambridge Street, Boston, MA 02114.
Author contributions: A.T., R.P., S.C.K., and P.N.T. designed research; A.T., R.P., and S.C.K. performed research; A.T., R.P., S.C.K., and P.N.T. analyzed data; and A.T., S.C.K., and P.N.T. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0813139106